ADAMTS 13 in non-thrombotic thrombocytopaenic purpura conditions

British Journal of Haematology

Volumn 141, Issue 2, 2008, Pages 262-265

  Scully, M ^a   Liesner, R ^b   Burgess, C ^b   Lawrie, A ^a   Machin, S ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

ADAMTS 13; Intensive care unit; Von Willebrand Factor Antigen (VWF:Ag)

Indexed keywords

VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME DEFICIENCY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOASSAY; INTENSIVE CARE UNIT; LETTER; NON THROMBOTIC THROMBOCYTOPENIC PURPURA; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; THROMBOCYTE COUNT; THROMBOCYTOPENIC PURPURA; TURBIDIMETRY;

ADAM PROTEINS; ADULT; CHILD; FEMALE; HUMANS; INFANT, NEWBORN; MALE; MIDDLE AGED; PURPURA, THROMBOCYTOPENIC; REFERENCE VALUES; VON WILLEBRAND FACTOR;

EID: 40949108552     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2008.06987.x     Document Type: Letter

References (5)

1. Crawley, J.T., Lam, J.K., Rance, J.B., Mollica, L.R., O'Donnell, J.S. Lane, D.A. (2005) Proteolytic inactivation of ADAMTS13 by thrombin and plasmin. Blood, 105, 1085 1093.
2. Fujikawa, K., Suzuki, H., McMullen, B. Chung, D. (2001) Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family. Blood, 98, 1662 1666.
3. Levy, G.G., Nichols, W.C., Lian, E.C., Foroud, T., McClintick, J.N., McGee, B.M., Yang, A.Y., Siemieniak, D.R., Stark, K.R., Gruppo, R., Sarode, R., Shurin, S.B., Chandrasekaran, V., Stabler, S.P., Sabio, H., Bouhassira, E.E., Upshaw, Jr., J.D., Ginsburg, D. Tsai, H.M. (2001) Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature, 413, 488 494.
4. Scully, M., Cohen, H., Cavenagh, J., Benjamin, S., Starke, R., Killick, S., Mackie, I. Machin, S.J. (2007) Remission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS-13. British Journal of Haematology, 136, 451 461.
5. Yarranton, H., Lawrie, A.S., MacKie, I.J., Pinkoski, L., Corash, L. Machin, S.J. (2005) Coagulation factor levels in cryosupernatant prepared from plasma treated with amotosalen hydrochloride (S-59) and ultraviolet A light. Transfusion, 45, 1453 1458.